Bonnell Brian Michael sold $1.1M of ICUI
Bonnell Brian Michael (Chief Financial Officer) sold 6,381 shares of ICU MEDICAL INC/DE (ICUI) at $175.00 ($1.12M total) on 2026-09-01 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The CFO's sale reduces his ownership but is likely a planned liquidity move; investors may watch for further insider activity.
Market read
A modest insider sale; may cause slight short‑term price pressure but unlikely to drive major market moves.
What to watch
The CFO's 10b5-1 plan pre‑arranged the sale, reducing the signaling strength.
Background
ICU Medical Inc. (ICUI) is a medical device company listed on Nasdaq. The filing is a standard Form 4 disclosure of an insider transaction.
Ticker impact
CFO Bonnell Brian Michael sold 6,381 shares for $1.12M via a 10b5-1 plan, reducing his stake to 56,062 shares.
Possible modest downside of 1-2% as the market digests the sale.
A $1.1M sale by a senior officer is material for a mid‑cap biotech, but the amount is not large enough to trigger a sharp move.
Market effects
May prompt scrutiny of other insider holdings in the medical device sector.
Limited to U.S. investors in ICUI.
Minimal
Counterpoint
The sale could be a routine liquidity event unrelated to company fundamentals.
Key entities
- CompanyICU Medical Inc.
Medical device manufacturer, ticker ICUI.
- ExecutiveBonnell Brian Michael
Chief Financial Officer of ICU Medical.
